Biohaven Pharmaceutical Holding Company Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.25
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-1.07
|
0.00
|
1.07
|
100.00%
|
|
2022-12-31
|
-1.21
|
0.00
|
1.21
|
100.00%
|
|
2022-09-30
|
-2.34
|
-1.75
|
0.59
|
25.21%
|
|
2022-06-30
|
-2.58
|
-6.21
|
-3.63
|
-140.70%
|
|
2022-03-31
|
-2.53
|
-2.97
|
-0.44
|
-17.39%
|
|
2021-12-31
|
-2.04
|
-3.01
|
-0.97
|
-47.55%
|
|
2021-09-30
|
-2.40
|
-2.63
|
-0.23
|
-9.58%
|
|
2021-06-30
|
-2.72
|
-3.23
|
-0.51
|
-18.75%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-10.93
|
|
2021-12-31
|
-13.08
|
|
2020-12-31
|
-13.04
|
|
2019-12-31
|
-10.97
|
|
2018-12-31
|
-6.20
|
|
2017-12-31
|
-5.46
|
|
2016-12-31
|
0.00
|